CEO

CEO Myoung-Jin Lee
Ph.D., Juris Doctor

Patent Attorney
Counselor at Law (NY, MA)
Technology Transfer Agent

Academic Experience

  • 1985 B.S. Department of Pharmacy, College of Pharmacy, Seoul National University, Korea
  • 1996, Ph.D. in Molecular Genetics, Catholic University of Daegu, Korea
  • 2008, Juris Doctor, University of New Hampshire School of Law, Concord, NH, U.S.A.
  • Admitted to Korean Patent Bar (2001)
  • Admitted to Massachusetts Bar (2008)
  • Admitted to United States Patent and Trademark Office (2008)
  • Admitted to New York Bar (2008)

Working Experience

  • Worked with Koreana Patent Firm in Seoul, Korea (2002-2004)
  • Worked with Davis & Bujold, PLLC in NH, U.S.A. (2007)
  • Worked with AGG Intellectual Property Law in MA, U.S.A (2008-2009)
  • KwangGaeTo Patent & Law Firm, Managing Partner (2009-2010)
  • ERUUM Patent Law Firm, Managing Partner (2011~2014)
  • MJ International Patent Law Firm, Managing Partner(present)
  • MJL Bio. Co., Ltd. CEO(present)

Publications

  • Contracts for Technology Transfer in Biotechnology (2015, IPMS).
  • Analysis of Patentability of biotechnology inventions through recent US cases.
    Intellectual Property,Vol.13:141-148(2010).
  • A novel angiogenic factor derived from Aloe vera gel: beta-sitosterol, a plant sterol.
    Angiogenesis 3(2): 117-123(1999).
  • Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Research 58: 348-351(1998).
  • Insulin-like growth factor II (IGF-II) secreted from HegG2 human hepatocellular carcinoma cell shows angiogenic activity.
    Cancer Letter 128: 41-46(1998).
  • Heteromeric gap junction channels in rat hepatocytes in which the expression of connexin26 is induced. Mol.
    Cells 8(3): 295-300(1998).
  • Isoform composition of connexin channels and selective permeability. Proceedings of Molecular Biology and Genetic Engineering 13: 491-493(1998).
  • Angiogenesis Inducing Mechanism of Aloe vera Gel. Arch. Pharma. Res. 21(3): 260-265(1998).
  • Incorporation of Lucifer Yellow into liposome. Nature Biotechnology (IRL Press) 8: 90-91(1997).

학력

  • 대구정화여자고등학교 졸업
  • 서울대학교 약학대학 약학과 졸업
  • 대구가톨릭대학교 대학원 약학박사
  • 미국 University of New Hampshire School of Law , Juris Doctor

자격

  • 약사
  • 한국변리사
  • 미국변리사 (미국 특허청 Patent Bar)
  • 미국변호사 (뉴욕주, 매사추세츠주)
  • 기술거래사

주요경력

  • 38회 변리사 시헙 합격
  • 미국 Davis & Bujold, PLLC 근무
  • 미국 AGG Intellectual Property Law 근무
  • 광개토국제특허법률사무소 대표변리사
  • 특허청/한국발명진흥회 특허자동화평가시스템 개발 참여위원
  • 바이오 의료분야 지재권공동대응협의체 위원
  • 한국발명진흥회 특허기술평가 전문위원
  • 대한변리사회 상임이사(제34대)
  • 여성변리사회 부회장
  • 특허법인 이룸 대표변리사
  • 성균관대학교 제약산업학과 초빙교수
  • 특허정보원 이사
  • 한국거래소 코스닥상장위원회 심의위원
  • 보건의료기술정책 심의위원회 전문위원
  • 現 명진 국제특허법률사무소 대표변리사
  • 現 ㈜엠제이엘 바이오 대표이사

주요 논문 및 저서

  • 바이오기술계약총서 (2015, IPMS).
  • 최근 미국판례 분석을 통한 생명공학발명의 특허성 고찰. 지식과 권리 통권13호:141-148 (2010).
  • A novel angiogenic factor derived from Aloe vera gel: beta-sitosterol, a plant sterol. Angiogenesis 3(2):117-123 (1999).
  • Insulin-like growth factor II induced by hypoxiamay contribute to angiogenesis of human hepatocellular carcinoma. Cancer Research 58: 348-351 (1998).
  • Insulin-like growth factor II (IGF-II) secreted from HegG2 human hepatocellular carcinoma cell shows angiogenic activity. Cancer Letter128: 41-46(1998).
  • Heteromeric gap junction channels in rat hepatocytes in which the expression of connexin26 is induced. Mol. Cells 8(3): 295-300(1998).
  • Isoform composition of connexin channels and selective permeability. Proceedingsof Molecular Biology and Genetic Engineering 13: 491-493(1998).
  • Angiogenesis Inducing Mechanism of Aloe vera Gel. Arch. Pharma. Res. 21(3): 260-265(1998).
  • Incorporation of Lucifer Yellow into liposome. Nature Biotechnology (IRLPress) 8: 90-91(1997).

Organization

service image

SERVICE

service image

CONTACT

Address
13th Floor, 445, Teheran-ro, Gangnam-gu, Seoul
TEL
82-2-558-5864
FAX
82-2-558-5865
E-mail
mjlee@mjlbio.com

Name *

Tel

Company

Subject

Questions *

In order to accept the reply sent by mail to collect your name, e-mail, contact details and information on the receipt.
(Will be used later in principle objective has been achieved and is discarded without delay, except when it is necessary to keep the company in accordance with the relevant laws and regulations or internal policies.)